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Abstract.  Detyrosinated (Glu) tubulin was prepared 
from porcine brain and mieroinjeeted into human 
fibroblasts and Chinese hamster ovary (CHO) cells. 
Glu tubulin assembled onto the ends of preexisting 
mierotubules and directly from the centrosome within 
minutes of its microinjeetion. Incorporation into the 
cytoskeleton continued until almost all of the microtu- 
bules were copolymers of Glu and tyrosinated (Tyr) 
tubulin.  However, further incubation resulted in the 
progressive and ultimately complete loss of Glu- 
staining microtubules. Glu tubulin injected into 
nocodazole-treated cells was converted to Tyr tubulin 
by a putative tubulin/tyrosine ligase activity. The ob- 
served decrease in staining with the Glu antibody over 
time was used to analyze microtubule turnover in 
microinjected cells. The mode of Glu disappearance 
was analyzed quantitatively by tabulating the number 
of Glu-Tyr copolymers and Tyr-only microtubules at 
fixed times after injection. The proportion of Glu-Tyr 
copolymers decreased progressively over time and no 
segmentally labeled microtubules were observed, indi- 
cating that microtubules turn over rapidly and individ- 
ually.  Our results are consistent with a closely regu- 
lated tyrosination-detyrosination cycle in living cells 
and suggest that microtubule turnover is mediated by 
dynamic instability. 
H 
ow do cells regulate the assembly and disassembly 
of their microtubules (MTs)?  I Many studies  have 
demonstrated a role for the interphase centrosome, 
basal bodies, and the mitotic poles in nucleating the growth 
of MTs (20, 39, see reference 6 for review), yet it is unclear 
how their distribution and stability is regulated (17, 28). Vari- 
ations in the complement of microtubule-associated  proteins 
and in the tubulin dimer itself may be important  factors in 
generating  functionally distinct MT populations  (%9, 41). 
Recent studies have shown that MTs rich in posttransla- 
tionally  modified alpha-tubulin  subunits  (detyrosinated  or 
acetylated) in cells of organisms ranging from sea urchins to 
humans, including such stable MT arrays as flagella and pri- 
mary cilia, exist as subpopulations within the cell (13, 21) in- 
dicating that they may play an important general role in MT 
function (12, 29).  Though the acetylation of alpha-tubulin 
has been correlated with flagellar assembly in Chlamydo- 
monas (22-24), a functional role for alpha-tubulin detyrosi- 
nation (and its subsequent retyrosination)  remains obscure. 
Recently, peptide-specific  antibodies have been prepared 
which distinguish  between tyrosinated (Tyr) and detyrosi- 
nated (Glu,  named for the COOH-terminal  glutamic  acid 
residue of detyrosinated tubulin)  alpha-tubulin  (13). With 
these antibodies, heterogeneity  in the MT population was re- 
vealed.  Many MTs stained only with the Tyr antibody and 
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some stained only with the Glu antibody. In addition,  some 
MTs stained with both.  Cytoplasmic MTs that stained with 
the Glu antibody were more limited in number and length 
than Tyr MTs, and were characterized as having a "sinuous" 
or curly morphology. Electron microscopic analysis by im- 
munogold staining of MTs confirmed the immunofluores- 
cence results: sinuous MTs contained elevated levels of Glu 
subunits,  while long straight MTs were enriched with Tyr 
subunits (10). 
If the detyrosination  of alpha-tubulin  altered the dimer 
functionally,  its assembly properties might be expected to 
differ from unmodified tubulin. The assembly properties of 
Glu and Tyr tubulin are similar as judged by in vitro assays 
(3,  19, 30),  but correlative  in vivo studies are lacking.  We 
therefore investigated the assembly competence of Glu tubu- 
lin microinjected into living cells, and followed the fate of 
the injected Glu tubulin over time. The rapid conversion of 
injected Glu tubulin to Tyr tubulin suggests that the tyrosina- 
tion state of alpha-tubulin is tightly controlled.  In addition, 
our results confirm an end-mediated mode of tubulin assem- 
bly in vivo, and suggest a mechanism for the turnover of  cyto- 
plasmic MTs. 
Materials and Methods 
Preparation of  Glu Tubulin 
Porcine brain MT protein was stored at -70°C as a pellet after two cycles 
of assembly and disassembly (5).  To prepare Glu  tubulin,  pellets were 
resuspended in 0.1 M K  + Pipes, pH 6.94, 1 mM EGTA, 1 mM MgCI2, and 
1 mM G'TP to a concentration of 5-10 nag protein/nil and incubated on ice 
for 30  rain.  After removal of cold-insoluble material  by centrifugation 
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lightly with the Glu antibody (arrow). Bar,  10  ~tm. 
(40,000 g for 30 min at 2°C), the supernatant was incubated with 2.5 gg/ml 
of pancreatic carboxypeptidase A (CPA; Vvbrthington Biochemicals, MaP 
vern, PA) for 20 min at 37°C.  This was the lowest concentration of CPA 
that completely removed the COOH-terminal tyrosine residue. After adding 
dithiothreitol (to 20 mM) to inactivate the CPA (19), MTs were polymerized 
for an additional 10 rain, collected by centrifugation (40,000  g for 30 rain 
at 35°C), and cold-depolymerized  as above. The final cold supernatant was 
run on DEAE-Sephadex (A-50;  Pharmacia Inc., Piscataway, NJ) according 
to Murphy (27).  This preparation was cycled with 10% dimethylsulfoxide, 
aliquoted, and stored in liquid nitrogen. The Glu tubulin obtained by this 
protocol was >98% tubulin and reacted exclusively with antibodies to Glu 
tubulin on immunoblots probed with antibodies either to Tyr or Glu tubulin. 
Although the in vitro assembly properties of  the Glu tubulin were not inves- 
tigated in detail, 30-40% of the tubulin cycled through an additional round 
of assembly-disassembly when the DEAE fraction of brain MAPs present 
during the detyrosination procedure was added back to the tubulin solution. 
MAP degradation could account for the lower value obtained for re,  assem- 
bly.  However, the tubulin was cycled after detyrosination to ensure that 
assembly-competent tubulin was injected. Dichlorotriazinylaminofluores- 
cein (DTAF)-labeled tubulin was prepared as described earlier (39). To pre- 
pare DTAF-GIu tubulin, a frozen aliquot of DTAF tubulin was thawed and 
allowed to assemble in 10% dimethylsulfoxide  before detyrosinating it with 
CPA. This material was then cycled once with dimethylsulfoxide and used 
immediately for microinjection. 
Figure 2.  Immunoblot of the su- 
pernatant of twice-cycled porcine 
brain  MT  protein  (C2S,  lanes a 
and d),  Glu  tubulin prepared by 
CPA  treatment  of  warmed  C2S 
material  (lanes  b  and  e),  and  a 
clarified,  whole-cell  extract  of 
356  cells (lanes c  and f),  show- 
ing the reactivities with the Tyr 
(lanes a-c) and  Glu  (lanes d-f) 
antibodies. The starting brain ma- 
terial contains roughly equal pro- 
portions of Glu and "Pyr tubulin as 
judged by this assay, and is con- 
verted  quantitatively  to  Glu  tu- 
bulin by CPA treatment. Tubulin 
treated  in this  manner was  used 
for all  of the  microinjection ex- 
periments. 356 cells contain very 
little Glu tubulin. 
Cells and Microinjection 
Human foreskin fibroblasts (type 356)  were obtained from the laboratory 
of  Dr. R. DeMars, Department of  Genetics, University of  Wisconsin (Madi- 
son, WI), and cultured in Ham's F-10 medium supplemented with 15 % fetal 
bovine serum. CHO cells were grown in F-10 medium with 10% fetal bovine 
serum. Both cell types were microinjected in Liebovitz's L-15 medium sup- 
plemented with 10 mM Hepes and 10-15% fetal bovine serum, having a final 
pH of 7.15-7.3.  Microinjection procedures were as previously described 
(39).  Aliquots of Glu  tubulin  (4  mg/ml) stored in liquid nitrogen were 
thawed and spun at  36,600  g  for 30  min at 4°C  before use.  Cells in a 
preselected area of the coverslip were injected over a 4-5-min time period, 
and the midpoint of that time period was used as time zero. Cell viability 
and health after microinjection were assessed as follows: (a) cells injected 
with either  buffer or tubulin  retained  a  normal  morphology by  phase- 
contrast microscopy and an unaltered MT network by immunofluorescence 
microscopy; (b) cells injected with buffer continued to divide; (c) buffer- 
injected cells monitored 18 h after injection had migrated from the injection 
site; and (d) injected cells treated with nocodazole and then released dis- 
played a Tyr-staining MT network indistinguishable from untreated cells. 
Tubulin/7)~'osine  Ligase (Tl'Lase)  Activity 
Experiments 
Cells on coverslips were first treated with nocodazole to completely depoly- 
merize all cytoplasmic MTs (25 gM for 3 h for the human fibroblasts, 2.5 
~tM for 1 h for CHO cells), and microinjected with Glu tubulin. Cells were 
then incubated at 37°C for established times before being released from 
nocodazole by three washes with drug-free medium. Cells were then in- 
cubated  just long enough (5 rain for CHO cells, 20 rain for the human fibro- 
blasts) to regrow MTs to the cell periphery. Cells were then fixed and pre- 
pared for double-label immunofluorescence. 
Turnover Experiments 
Nocodazole-treated cells were microinjected with Glu  tubulin as above, 
then released immediately from nocodazole and incubated at 37°C for fixed 
times  before the  immunofluorescence protocol  was  performed.  Photo- 
graphic prints of staining in both the Glu and Tyr channels were then ana- 
lyzed as follows. All detectable Glu MTs (40-60 per cell) were traced onto 
a  clear acetate sheet and overlayed onto the photograph of Tyr-staining 
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onto the ends of preexisting MTs (a and b) and directly from the centrosome (arrows in d).  Bar,  2  ~tm. 
MTs from the same cell. Almost all MTs were then classified as either Glu- 
Tyr copolymers or Tyr-oniy homopolymers, based on immunofluorescence 
staining.  A low percentage  (0-8%) of MTs were classified  as either Glu- 
only MTs or as containing Glu segments.  Data from several cells per time 
point (150-300 total MTs counted) were routinely pooled and weighted ac- 
cording to the number of MTs each cell contributed to the total. For exam- 
ple, a cell contributing  40% of the total MTs counted for a time point would 
be weighted as follows: (0.4) × (percent of MTs in classification)/total  num- 
ber of MTs in that time point. The weighted proportions were then plotted 
as the proportion of MTs of each classification versus time. Standard devia- 
tions were calculated weighting  the value (X-X)  2 in the same way. 
Immunofluorescence 
Double-label immunofluorescence  was used in all experiments.  Cells grown 
on coverslips  were rinsed briefly in PHEM buffer (36) containing 60 mM 
Pipes, 25 mM Hepes, pH 6.94, 10 mM EGTA, 2 mM MgC12, extracted for 
one min in PHEM plus 0.1% vol/vol  Triton X-100, and fixed with 0.7% 
glutaraldehyde  in PHEM  buffer.  Unreacted glutaraldehyde  was  reduced 
with  I  mg/mi of sodium borohydride.  Kilmartin's rat anti-l~yr antibody 
(clone  YL  1/2,  1:500  dilution of ascites  fluid;  Accurate  Chemical  & 
Scientific Corp., Westbury, NY) was applied simultaneously  with a rabbit 
anti-Glu antibody (1:50 dilution of serum, reference 13) or a rabbit antibody 
prepared against fluorescein  (1:100 dilution of serum, reference  U). Simi- 
larly, a rhodamine-conjugated  anti-rabbit IgG and a fluorescein-conjugated 
goat anti-rat IgG (Kirkegaard  & Perry Laboratories,  Inc., Gaithersburg, 
MD)  or  fluorescein-eonjugated  goat  anti-rabbit  (Kirkegaard  &  Perry 
Laboratories,  Inc.) and Texas red-conjugated goat anti-rat antibodies (Jack- 
son Immunoresearch, Avondale,  PA)  were  applied  simultaneously  after 
washing the cells free of primary antibody.  Coverslips  were mounted in a 
medium containing 1 mg/mi ofp-phenylenediamine as an anti-bleaching 
agent.  Cells were examined with a Zeiss Universal microscope equipped 
with epifluorescence  (Carl Zeiss,  Inc., Thorn~,,aaod, NY) using Planapo- 
chromat x63 (1.4 NA) and Planachromat xl00 (1.3 NA) objectives,  Photo- 
graphs were taken with Kodak Tri-X negative film and developed with Kodak 
HC-110 developer. 
Results 
Distribution of T~r- and Glu-staining MTs in 
Untreated Mammalian Cells 
Cytoplasmic MTs were colabeled with a rat monoclonal anti- 
body specific for the Tyr form of alpha-tubulin and a rabbit 
Webster et al. Assembly of Detyrosinated Tubulin In Vivo  267 Figure 4. Injected Glu tubulin assembles uniformly into cytoplasmic  MTs (a and b) of 356 cells within 15-20 min, while further incubation 
(90 min, c and d) results in the disappearance of Glu-staining MTs. Bar, 10 ttm. 
polyclonal Glu  tubulin  antibody (13, 43).  Tyr antibodies 
stained essentially the entire MT network in both cell types 
used (Fig.  1 a), and gave immunofluorescence patterns that 
were  essentially  indistinguishable from  an  antibody  that 
stains both Tyr and Glu MTs (43).  Glu staining of MTs was 
not elevated by use of increased antibody concentrations or 
by the omission of the Tyr antibody (data not shown). Bleed- 
through of Tyr staining onto the Glu-staining network was 
prevented by application of  the secondary antibody combina- 
tions outlined in Materials and Methods. 
Type 356 fibroblasts from exponentially growing cultures 
displayed few or no Glu MTs (Fig.  1 b). Occasionally, Glu 
MTs were observed within long cell processes (I>20 ttm), 
but these MTs often ended abruptly upon entering the cyto- 
plasm of the cell body. In addition, short centrosomal Glu 
MTs were observed more frequently in confluent cultures, 
but still constituted a visually small subset of the total MT 
network. Also, the Glu antibody frequently stained the cen- 
triole as a light dot. Immunoblots of  total extracts of 356 cells 
probed with either the Tyr or Glu antibody (Fig. 2, lanes c 
and e) indicated abundant levels of Tyr but low levels of Glu 
tubulin, consistent with the lack of Glu staining observed 
by immunofluorescence. Due to the lack of endogenous Glu- 
staining MTs in the 356 cells and the paucity of Glu tubulin 
in the subunit pool, the mode of incorporation of Glu tubulin 
into the preexisting MT network could be examined without 
confusing newly labeled MTs with preexisting Glu MTs. 
In contrast to the lack of Glu MTs observed in human 
fibroblasts, CHO cells consistently displayed Glu MTs (usu- 
ally <25 per cell), most of which arose from the centrosome. 
The Glu MTs were generally shorter than their Tyr counter- 
parts, and displayed a sinuous morphology described earlier 
(13). MTs in CHO cells were less densely packed than in the 
356 cells and did not compose parallel bundles. Thus, in- 
dividual MTs were more easily identified in CHO cells and 
these cells were used in addition to the human fibroblasts to 
quantify the distribution of Glu and Tyr MTs after microin- 
jection of Glu tubulin. 
Incorporation of  Glu Tubulin into Cytoplasmic MTs 
Porcine brain MTs were detyrosinated with CPA  (Fig.  2, 
lanes b and e), and subsequently the purified Glu tubulin was 
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Figure 5. Schematic drawing of the assay used to detect the activity 
of tubulin/tyrosine ligase. Ceils were first treated with noeodazote 
(a) to depolymerize cytoplasmic MTs. After injection of Glu tubu- 
lin (b), cells were incubated for either short or longer periods of 
time (c) before release from nocodazole (d).  MTs from injected 
cells were then analyzed by immunofluorescence  for the presence 
of Glu  MTs. (Open circles) Tyr  subunits; (solid circles) Glu 
subunits. 
microinjected into human fibroblast cells. We microinjected 
~,5 % of the cell volume with 4 mg/ml tubulin, an amount 
which has been estimated to increase the dimer pool by 
'~15% (39).  Glu staining was observed at the distal (+) ends 
of preexisting MTs at the cell periphery within 7 min of Glu 
tubulin microinjection (Fig.  3, a  and b).  Glu-labeled seg- 
ments were also observed closer to the centrosome. How- 
ever, due to a greater congestion of MTs in these regions, it 
was not determined whether these Glu segments labeled the 
ends of centrosomal MTs or represented free MTs. With few 
exceptions, the peripheral Gin-staining MTs always stained 
with the Tyr antibody as well. In addition to end-labeling, 
short MTs arising directly from the centrosome stained with 
the Glu antibody, suggesting that new MT growth occurred 
during this time (Fig. 3, c and d). Within several minutes of 
injection, CHO cells had already incorporated Glu tubulin 
uniformly into many MTs, and end-labeling was no longer 
apparent. 
With longer incubation, the injected 356 cells displayed 
continuous Glu staining along most of their MTs.  The cell 
in Fig. 4 (a and b) was fixed 15 min after microinjection, and 
shows a network of Glu MTs that is very similar to the Tyr 
pattern. End-labeled MTs were no longer observed and Tyr- 
only MTs were found infrequently, suggesting that the in- 
jected Glu tubulin had, by this time, become uniformly in- 
corporated into MTs, and that the cytoplasmic network had 
turned over within that time. In a typical experiment, from 
20 to 30 cells per coverslip were injected over a period of  4-5 
min, and minor heterogeneity in the staining pattern was ob- 
served.  For example, the intensity of Glu staining varied 
slightly in an average of one or two cells per coverslip,  de- 
pending  on  the  actual  volume  of material  injected  and 
whether a particular cell was injected first or last. In general, 
the pattern of staining was very consistent, and by 15-20 min 
the maximum number of Glu-staining MTs was observed. 
Retyrosination of  Injected Glu Tubulin when 
MTs Are Absent 
Glu staining of MTs from microinjected cells disappeared 
with time (Fig. 4, c and d). After 90 rain of incubation, Glu 
MTs were detected in only a very few injected cells.  The 
most likely explanation is that the injected Glu tubulin had 
been retyrosinated, presumably by the endogenous TTLase. 
In vitro studies have shown that the tubulin dimer is the 
preferred  substrate  for  retyrosination (3,  30).  Therefore, 
putative Tl'Lase activity was assayed by first depolymerizing 
cytoplasmic MTs with nocodazole to provide the optimal 
substrate for the enzyme. Selected cells were then microin- 
jected with Glu tubulin and incubated for increasing times 
in the presence of nocodazole before the MTs were allowed 
to regrow in the absence of drug (Fig. 5). As shown in Fig. 
6, a and b, human fibroblasts injected with Gin tubnlin and 
incubated in nocodazole-containlng medium for 30 rain be- 
fore drug release still contained enough Glu tubulin to be ob- 
served as Glu MTs by immunofluorescence. However,  cells 
incubated for 60 min and then released from nocodazole 
showed no Glu staining, indicating that the amount of Glu 
tubulin remaining was significantly less than at the earlier 
time point (Fig. 6, c and d) and had fallen below the thresh- 
old of detection. Cells released from nocodazole after less 
than 30 min showed qualitatively similar Glu staining pat- 
terns, though possibly greater in intensity. 30 min was the 
longest incubation time in nocodazole after which, following 
drug release and MT regrowth, Glu staining of MTs was con- 
sistently observed. Similar results were obtained using ClIO 
cells. 
An alternative explanation for the loss of Glu staining over 
time would be that the injected Glu tubulin gradually lost its 
ability to assemble into MTs. To test the continued assembly 
competence of injected Glu tubulin independently of its re- 
tyrosination, tubulin labeled with DTAF was detyrosinated 
and injected into nocodazole-treated cells as before.  The 
fluorescein hapten marked injected subunits, while the de- 
tyrosinated tubulin provided a substrate for the TTLase. In- 
jected cells were then either released immediately from the 
drug or after an additional 60-min incubation in nocodazole, 
and stained with either the fluorescein antibody or the Glu 
antibody and counterstained with the Kilmartin antibody 
(Fig. 7). Cells released from nocodazole immediately after 
injection showed intense Glu-staining MTs and weaker label- 
ing with the antifluorescein antibody (Fig. 7, a  and c). In 
both cases, injected ceils displayed a  normal Tyr-staining 
MT array (Fig. 7, b and d). 
Webster et al. Assembly of Detyrosinated Tubulin In Vivo  269 Figure 6. Typical results from an assay for tubulin/tyrosine ligase activity on 356 cells. Injected cells incubated in nocodazole for 30 rain 
before drug release display MTs composed of both Glu and Tyr subunits (a and b). Cells incubated for 60 min before release show only 
Tyr-staining MTs (c and d). Bar, 10 Ism. 
Cells released from nocodazole 60 min after injection of 
DTAF-Glu tubulin showed staining for the fluorescein hapten 
similar in intensity to that observed immediately after injec- 
tion (Fig. 7 e). At this time Glu staining in similar cells was 
absent (Fig. 7 g), though Tyr-staining MTs remained (Fig, 
7, fand h). By this criterion, injected Glu tubulin remained 
able to assemble into MTs at the time that staining for the 
Glu  subunits disappeared,  indicating that the loss of Glu 
staining occurred via retyrosination of the injected dimers. 
Retyrosination of  Injected Glu Tubulin when 
MTs Are Present 
The turnover of tyrosine on MTs was studied in more detail. 
As depicted in the flow diagram in Fig. 8, nocodazole-treated 
356  and  CHO  cells  were  injected with Glu  tubulin  and 
released immediately from the drug, allowing immediate and 
uniform Glu tubulin incorporation into the cytoskeleton. At 
specific times after release injected cells were fixed and pre- 
pared for immunofluorescence. Injected 356 cells allowed to 
recover only a short time displayed asters of MTs composed 
of both Glu and Tyr subunits (Fig. 9, a and b). With longer 
incubation, Glu staining was uniform over a majority of the 
cytoplasmic MTs and later disappeared (Fig. 9,  c-f),  in a 
manner similar to that depicted in Fig. 4. 
For each time point after release, the proportion of cyto- 
plasmic MTs that stained with the Glu antibody was tabu- 
lated by counting the number of Glu MTs visible in immu- 
nofluorescence micrographs  and  comparing  that  number 
with the number of Tyr-staining MTs from the same ceil. A 
Glu or Tyr MT is defined here as any MT that stains visibly 
by immunofluorescence with the appropriate antibody, and 
may not reflect the absolute amount of each species present 
in each MT (10). Glu MTs that did not also stain with Kilmar- 
tin antibody were rare. Fig.  I0 shows that Tyr MTs can be 
discerned from Glu-Tyr copolymers by comparison on pho- 
tographic prints of  the staining patterns obtained with the two 
antibodies. It should be noted that, as represented by the MTs 
seen here, staining heterogeneity is rarely observed; MTs are 
usually either Tyr homopolymers or Glu-Tyr copolymers 
along their observable lengths. After classifying all discern- 
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injected into 356 cells retains 
its assembly  competence  but 
loses  its  reactivity  with  the 
Gin antibody. Cells were dou- 
ble-labeled  with  either  anti- 
fluorescein and Kilmartin anti- 
bodies, or Glu and Kilmartin. 
Nocodazole-treated  cells  re- 
leased from the drug immedi- 
ately after injection (a-d) dis- 
play  DTAF labeling  (a)  that 
mimics the  Tyr-staining  pat- 
tern  (b),  while  the  intensity 
of Glu staining in identically 
treated  cells  (c)  is  high  and 
also  resembles  the Tyr-stain- 
ing network (d). Cells released 
from nocodazole 60 rain after 
injection (e-h)  show a IYrAF 
pattern  similar  in  intensity 
to  that  observed  in a,  while 
Glu staining of an identically 
treated cell is absent (g). l~r 
staining is displayed in b, d, f, 
and h.  Bar,  10 ltm. 
able MTs as either Tyr homopolymers or Glu-Tyr copoly- 
mers (or rarely,  segmentally labeled MTs), the number of 
each type was converted to the proportion of the total MT 
population and plotted against time. 
In  each  individual  356  cell  the  proportion  of Glu-Tyr 
copolymers decreased progressively over time (Fig. 11, left), 
corresponding to a complementary increase in Tyr-only MTs, 
which suggests that the transition from Glu to Tyr occurred 
MT by MT and not to the general MT population at once. 
At early times <100% of the MTs were counted as Glu, and 
this might be accounted for by the poorer resolution of dim- 
mer Glu MTs within the asters, though some type of subunit 
sorting mechanism cannot be ruled out. Immunofluorescence 
staining of in vitro polymerized brain tubulin with Glu and 
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Figure 8. Schematic drawing of the assay used to analyze turnover 
of Glu tubulin in MTs. MTs were depolymerized with nocodazole 
as in the ligase assay (a), but after injection ofGlu tubulin (b) cells 
were released immediately from the drug (c), and incubated for 
short or long periods of time before fixing (d). (Open circles) Tyr 
subunits; (solid circles) Glu subunits. 
Tyr antibodies has failed to reveal any such sorting (our un- 
published observation). By 90 min the proportions of Glu- 
Tyr copolymers and Tyr-only homopolymers approached 
the levels found in uninjected cells. A similar pattern of loss 
of  Glu fluorescence was observed when the nocodazole treat- 
ment was omitted, but the time of maximum Glu tubulin in- 
corporation (time zero in the turnover experiments) was then 
more difficult to determine consistently. 
Turnover of tyrosine in the presence of MTs was also in- 
vestigated in CHO ceils for two reasons. First, the radially 
oriented MT array facilitated the detection and classification 
of individual MTs. Second, it was of interest to analyze tubu- 
lin tyrosine turnover in a cell type that contained appreciable 
numbers of Glu MTs. As for 356 cells, immediately after re- 
lease from nocodazole, Gin tubulin appeared in almost all 
MTs. However, in contrast to 356 cells, CHO ceils still dis- 
played Glu MTs at long times after injection. In no instance 
was a progressive shortening of Glu MTs observed. As seen 
in Fig.  11 (right), the progressive loss of Glu-staining MTs 
was accompanied by an increase in the proportion of Tyr- 
only  MTs  until  approximate  steady-state values  were  at- 
tained, as in the results obtained for 356 cells. 
Discussion 
In an attempt to understand the function of Glu MTs within 
the cell, we first assessed the ability of Glu tubulin, a natu- 
rally occurring, posttranslationally modified form of tubu- 
lin, to assemble into cellular MTs. In an earlier study (39), 
fluorescein-haptenized tubulin was found to incorporate into 
cellular MTs by an end-mediated process.  Having used a 
different probe (Gin tubulin) in the same cell type (human 
fibroblasts), we now confirm the earlier results that tubulin 
assembles rapidly at the distal ends of preexisting MTs and 
directly from the centrosome. These results are also consis- 
tent with the in vitro assembly properties of Glu tubulin, 
which are essentially indistinguishable from those of Tyr 
tubulin (3, 19, 30). With further incubation Glu tubulin was 
found to incorporate uniformly into the MT network, as in 
the Tyr MT pattern, during a  time course similar to that 
found in other ceils injected with tubulin derivatized with 
fluorescein (39) or biotin (38) haptens. 
Unlike the results found with DTAF or biotinylated tubu- 
lin,  Glu  staining  of microinjected cells  disappeared  with 
time. We considered two possibilities: (a) the microinjected 
Glu tubulin incorporated into MTs, reentered the cytoplas- 
mic  pool,  and  eventually  became  assembly  incompetent 
through some unspecified mechanism, or (b) the microin- 
jected Glu tubulin became retyrosinated by an endogenous 
TTLase activity.  The  results  of the  ligase  assays  where 
DTAF-labeled Glu tubulin was  injected demonstrated the 
continued ability of the injected subunits to assemble into 
MTs. Thus, it was concluded that the observed loss of Gin 
fluorescence arose not from the limited half-life of the in- 
jected tubulin but from its modification (tyrosination) after 
injection. 
Injected Glu tubulin was rapidly converted to Tyr tubulin. 
In nocodazole-treated 356 cells, between 30 and 60 rain was 
required to drop the level ofGlu subunits below the threshold 
of visibility of immunofluorescence.  Likewise,  a  similar 
amount of time was required from the point of maximum in- 
corporation of Glu tubulin into MTs (15-30 min) to its disap- 
pearance in otherwise untreated cells (90 min, Fig. 4). Could 
an endogenous TTLase account for this conversion of in- 
jected Glu subunits to Tyr? From the estimated number of 
ligase molecules per cell (4 x  103, references 31 and 37) and 
an estimated turnover number of 30 tyrosines per ligase mol- 
ecule per minute (37), an average tissue culture cell could 
tyrosinate roughly 3.6  ×  106 dimers within 30 min, which 
exceeds the estimated 3  x  106 Gin dimers injected (15, 39). 
Given the approximate nature of the assumptions, we con- 
sider the agreement to be good and we conclude that the en- 
dogenous TTLase could convert all of the injected Glu tubu- 
lin within the time span of a routine ligase assay.  Similar 
rates of tyrosine turnover were obtained by Thompson et al. 
(40) in cultured muscle ceils, where they found the half-life 
of tyrosine on alpha-tubulin at steady-state to be "~37 min. 
The observed loss of Glu-staining MTs over time provided 
us with a tool with which to investigate MT turnover, but its 
use required that two assumptions be met. First, we assumed 
that TTLase activity occurred predominately on free tubulin 
subunits. In vitro studies (3, 30) support this assumption. In 
addition, the TTLase needed to work rapidly enough for loss 
of Glu fluorescence on MTs to be correlated with MT turn- 
The Journal of Cell Biology, Volume  105, 1987  272 Figure 9.  356 cells released  from nocodazole  immediately after Glu tubulin injection and incubated for 9 rain regrow asters which are 
copolymers of Glu and Tyr tubulin (a and b). After a 30-min incubation  there are still many Glu-staining  MTs present (c and d), but after 
90 min of incubation only Tyr-staining MTs remain (e and f). Bars:  (a and b) 5 ~m; (c-f)  10 ~tm. 
Webster et al. Assembly of Detyrosinated Tubulin In Vivo  273 Figure  10. High magnification micrograph of an area of a 356 cell incubated for 30 min after Glu tubulin injection, displaying both MTs 
that stain only with a Tyr antibody (double arrows) and Glu-Tyr copolymers (/arge arrowheads). There is no staining heterogeneity along 
the length of these MTs. MTs of both classes were tabulated and plotted for each time point assayed (Fig. U). Bar, 5 Ixm. 
over. The similarity in the kinetics of retyrosination between 
ceils treated with or without nocodazole confirmed that Glu 
subunits released from MTs would be quickly retyrosinated, 
most likely before readdition onto a different MT. 
Haptenized tubulins  have allowed the kinetics of incor- 
poration into MTs to be examined, but the conclusions have 
necessarily been qualified due to perturbation of the tubulin 
pool size caused by the injection and the possible modifica- 
tion of the assembly kinetics due to the derivatized tubulin. 
In this study injected cells were allowed to incorporate Glu 
tubulin uniformly into cytoplasmic MTs before the analysis 
of MT turnover was made, minimizing the problem of injec- 
tion perturbation. It is conceivable that the elevated level of 
Glu subunits within MTs during the assay perturbed normal 
dynamics. However, the rate of incorporation of Glu dimers 
onto preexisting MTs was similar to that observed with hap- 
tenized tubulin probes. 
The turnover of COOH-terminal tyrosine on alpha-tubulin 
was considered in light of three current models for MT dy- 
namics:  direct  polymer  modification,  treadmilling,  and 
dynamic instability (Fig.  12). In the polymer modification 
model retyrosination would occur either directly on the poly- 
mer or via subunit exchange along the entire length of MTs. 
This model would predict a gradual and uniform dimming 
of Glu immunostaining fluorescence on all MTs until the 
threshold of detection was reached. This gradual and uni- 
form dimming was not observed. This negative result is con- 
sistent with the demonstrated preference of TTLase for tubu- 
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Figure 11. Turnover of Glu MTs in human hbroblasts (left) and CHO cells (right). Nocodazole-treated cells were injected with Gin tubulin 
and then immediately released from the drug block to permit the formation of Glu-Tyr copolymers. With time after reformation of the 
MT array, the proportion of Glu-Tyr copolymers (solid circles) decreased progressively while the proportion of Tyr MTs (solid triangles) 
increased in a complementary manner until steady-state levels were reached (open symbols). 
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Figure  12.  Three  possible 
models for the turnover of the 
COOH-terminal  tyrosine  of 
alpha-tubulin. In a tyrosine is 
either  added directly  to  the 
polymer-bound  alpha subunit, 
or detyrosinated subunits ex- 
change with the soluble pool 
along the entire length of the 
MT. In b tyrosine is added to 
free dimers that have entered 
the subunit pool by MT tread- 
milling, and in c retyrosina- 
tion  occurs  on  free  dimers 
released  from  the  polymer 
pool via dynamic instability. 
lin dimers (3, 30) and tubulin/tyrosine  carboxypeptidase (the 
specific detyrosinating enzyme) for MTs (1, 2,  14,  18), and 
does not support direct polymer modification as the mode of 
MT tyrosination. 
In the treadmilling and dynamic instability models, loss of 
Glu-Tyr copolymer would occur by end-wise exchange of 
MT subunits with the subunit pool. Treadmilling would be 
detected as a gradual shortening of Glu MT domains prox- 
imal to the centrosome accompanied by a lengthening, at the 
same rate,  of Tyr domains at the distal ends of the MTs. 
Treadmilling would predict a high level of segmentally la- 
beled MTs during turnover, especially at time points after in- 
jection corresponding to virtually complete dimer retyrosi- 
nation by the TTLase (30-60 min in a ligase assay). At these 
times, Glu-Tyr copolymers were observed side by side with 
Tyr MTs, and did not exhibit any observable staining hetero- 
geneity along their lengths. Previous studies have indicated 
the in vitro rate of MT treadmilling to be on the order of 
micrometers per hour (4, 25, 32).  If similar rates occurred 
in vivo, TTLase activity should reduce the level of Glu di- 
mers sufficiently for segmental labeling to be observed at 
intermediate stages of MT turnover.  Further, treadmilling 
would be much too slow a mechanism to account for the turn- 
over rates recorded in this study.  In accordance with this 
view, recent photobleaching studies (11, 33, 42) have failed 
to observe treadmilling in the central spindle of various cells 
during mitosis. Though MT dynamics might be fundamen- 
tally different  in mitosis, they are also reportedly more rapid. 
In addition, treadmilling has not been observed in studies of 
interphase cells (34,  35).  It therefore seems unlikely that 
treadmilling could account for the loss of Glu fluorescence 
observed in this study. 
The dynamic instability model, also derived from in vitro 
studies (16, 26),  suggests that MTs exchange subunits with 
the dimer pool by depolymerizafion of individual MTs after 
the loss of their GI'P cap. The loss of Glu fluorescence from 
individual fibers over time can be explained by this model, 
since the Glu subunits released from an MT would become 
available to the TTLase for retyrosination before reassembly 
into a new MT. The model would predict that individual MTs 
would lose their Glu subunits as they depolymerized and 
would then regrow using newly tyrosinated subunits. Since 
depolymerization of MTs occurs individually, dynamic in- 
stability would predict that Glu-Tyr copolymers coexist side 
by side with Tyr MTs at intermediate stages of the turnover 
process,  as was in fact observed.  This hypothesis is also 
compatible with the observed level of TTLase activity in 
both cell types studied. The rate of conversion of Glu to Tyr 
tubulin in 356 cells is faster than in CHO cells (Fig.  11). 
Whether this is due to more uniform MT turnover or to other 
factors, such as the balance between endogenous TTLase 
and carboxypeptidase activities, is not known. 
In conclusion, the observed progressive loss of Glu MTs 
with time strongly suggests that MTs turn over rapidly and 
individually as predicted by dynamic instability. The results 
are  compatible with a  cyclic model for the tyrosination- 
detyrosination of alpha-tubulin (14). Although Glu tubulin is 
assembly competent, under steady-state conditions in cells 
most unpolymerized tubulin would be in the Tyr form be- 
cause of  an active TTLase. Detyrosination would occur prin- 
cipally as a  postpolymerization process through a  tubulin 
carboxypeptidase bound to the MTs. Subsequent depolymer- 
ization would release Glu subunits for retyrosination. The 
function of  the tyrosination-detyrosination  cycle and its rela- 
tion to the turnover of MTs as mediated by dynamic instabil- 
ity are important questions for further study. 
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